Kunming Pharmaceuticals, Inc.
Registry sponsor category
Industry
- Other names
- Kunming Pharmaceuticals, Inc.
- Company name
- Kunming Pharmaceuticals, Inc.
- Organisation type
- Industry
- Registry sponsor category
- Industry
- Publicly traded (proxy)
- No
- Listing at source
- Listed
Related records
Trials (10)
- A Multicentre, Randomised, Double-blind, Positive-control Clinical Trial Evaluating Dihydroartemisinin Tablets for the Treatment of Discoid Lupus Erythematosus
- A Phase I Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetic Profile of Gastrodin Injection in Healthy Chinese Subjects
- A Trial to Evaluate KPC000154 Tablets in Healthy Subjects
- Comparing of the Pharmacokinetics, Immunogenicity and Safety of MV088 and Prolia® in Healthy Adults.
- Efficacy and Safety of the KPCXM18 Injection in Patients With Acute Ischemic Stroke
- Exploratory Study of DHA in Systemic Lupus Erythematosus Patients
- Safety,Tolerability, and Pharmacokinetic of KPCXM18 for Injection
- Safety,Tolerability, Pharmacokinetic,Pharmacodynamics and Efficacy of KY100001 in Patients With Advanced Solid Tumors
- Study of the KPCXM18 Injection for Treatment of Acute Ischemic Stroke
- Study to Evaluate the Efficacy and Safety of Colchicine Tablets in Patients With COVID-19